CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 827 enrolled
Drug / intervention
Prone positionprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04407468
NCT04407468N/ACompleted
CompareCT.gov

Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19 (APRONOX)

Hospital General San Juan del Rio·observational·Posted May 29, 2020·Updated Jul 15, 2020

In Brief

An observational study evaluating Prone position for COVID and 2 related conditions. Completed, enrolled 827 participants across 6 sites.

Detailed Summary

The prone position strategy for patients with acute respiratory distress syndrome (ARDS) is simple and cost-effective from the first description on its use in patients with acute respiratory failure to improve hypoxemia. Different studies have investigated its safety and efficacy in various clinical settings, demonstrating that its early use in combination with non-invasive mechanical ventilation (NIV) or high-flow oxygen therapy can reduce intubation rate and mortality in ARDS. In the Coronavirus disease 2019 (COVID-19) pandemic, high-value medicine and resource optimization are critical.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID, ARDS, Pneumonia
CountriesMexico
CollaboratorsInstituto Nacional de Cancerologia de Mexico

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedMay 29, 2020
Enrollment StartMay 1, 2020
Primary CompletionJul 13, 2020
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 6.1 years ago

Interventions

Prone positionprocedure

Position of the patient in which he is face down, for an improvement in oxygenation